The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy

Abstract Background Anti-HER2 targeted therapy has significantly reduced the recurrence and death of HER2-overexpressing breast cancer patients, but might lead to cardiotoxicity. Some patients with normal myocardial function may suffer from subclinical myocardial dysfunction after anti-HER2 targeted...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Zhang, Siyuan Wang, Chao Yu, Wenying Jin, Dan He, Xiaoxiao Hu, Shu Wang, Tiangang Zhu
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13377-1
Tags: Add Tag
No Tags, Be the first to tag this record!